Abstract
C21H25NO5, monoclinic, P21/n (no. 14) a = 10.4501(19) Å, b = 15.750(3) Å, c = 12.043(2) Å, β = 102.625(3)°, V = 1934.3(6) Å3, Z = 4, Rgt(F) = 0.0406, wRref(F2) = 0.1177, T = 296(2) K.

The crystal structure is shown in the figure. Tables 1 and 2 contain details on crystal structure and measurement conditions and a list of the atoms including atomic coordinates and displacement parameters.
Data collection and handling.
| Crystal: | Yellow block |
| Size: | 0.39 × 0.35 × 0.27 mm |
| Wavelength: | Mo Kα radiation (0.71073 Å) |
| μ: | 8.70.9 cm−1 |
| Diffractometer, scan mode: | Bruker APEX-II, φ and ω |
| 2θmax, completeness: | 50°, >99% |
| N(hkl)measured, N(hkl)unique, Rint: | 9762, 3406, 0.019 |
| Criterion for Iobs, N(hkl)gt: | Iobs > 2 σ(Iobs), 2764 |
| N(param)refined: | 249 |
| Programs: | Bruker programs [6], SHELX [7] |
Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2).
| Atom | x | y | z | Uiso*/Ueq |
|---|---|---|---|---|
| C1 | 0.60107(15) | 0.17023(10) | 0.86364(14) | 0.0370(4) |
| C2 | 0.71576(15) | 0.20068(9) | 0.93346(12) | 0.0328(3) |
| C3 | 0.81016(17) | 0.27566(12) | 1.10414(15) | 0.0463(4) |
| H3A | 0.7848 | 0.3004 | 1.1690 | 0.069* |
| H3B | 0.8747 | 0.2324 | 1.1291 | 0.069* |
| H3C | 0.8464 | 0.3188 | 1.0638 | 0.069* |
| C4 | 0.83370(14) | 0.19122(9) | 0.90157(13) | 0.0328(3) |
| H4A | 0.9102 | 0.2110 | 0.9492 | 0.039* |
| C5 | 0.84017(14) | 0.15249(9) | 0.79909(13) | 0.0315(3) |
| C6 | 0.72555(15) | 0.12342(10) | 0.73030(13) | 0.0382(4) |
| H6A | 0.7279 | 0.0977 | 0.6613 | 0.046* |
| C7 | 0.60700(15) | 0.13201(11) | 0.76252(14) | 0.0420(4) |
| H7A | 0.5306 | 0.1117 | 0.7152 | 0.050* |
| C8 | 0.97209(14) | 0.14147(9) | 0.76621(13) | 0.0319(3) |
| H8A | 0.9555 | 0.1249 | 0.6859 | 0.038* |
| C9 | 1.05293(15) | 0.07186(9) | 0.83628(13) | 0.0354(4) |
| C10 | 1.01773(17) | −0.01669(11) | 0.80771(17) | 0.0468(4) |
| C11 | 0.8835(3) | −0.10788(14) | 0.6768(3) | 0.0973(10) |
| H11A | 0.8176 | −0.1053 | 0.6075 | 0.146* |
| H11B | 0.9570 | −0.1402 | 0.6644 | 0.146* |
| H11C | 0.8478 | −0.1346 | 0.7350 | 0.146* |
| C12 | 1.15156(15) | 0.09033(10) | 0.92517(14) | 0.0370(4) |
| C13 | 1.23373(19) | 0.03010(12) | 1.00703(18) | 0.0573(5) |
| H13A | 1.2966 | 0.0615 | 1.0617 | 0.086* |
| H13B | 1.1785 | −0.0020 | 1.0456 | 0.086* |
| H13C | 1.2788 | −0.0079 | 0.9663 | 0.086* |
| C14 | 1.14633(14) | 0.23790(9) | 0.87189(12) | 0.0309(3) |
| C15 | 1.04808(14) | 0.22405(9) | 0.77986(12) | 0.0304(3) |
| C16 | 1.01231(14) | 0.28970(10) | 0.69647(13) | 0.0340(4) |
| C17 | 1.08227(17) | 0.37406(10) | 0.71625(14) | 0.0422(4) |
| H17A | 1.0223 | 0.4184 | 0.6817 | 0.051* |
| H17B | 1.1551 | 0.3736 | 0.6782 | 0.051* |
| C18 | 1.13435(16) | 0.39564(10) | 0.84131(14) | 0.0390(4) |
| C19 | 1.21672(15) | 0.32064(10) | 0.89541(14) | 0.0386(4) |
| H19A | 1.2965 | 0.3184 | 0.8667 | 0.046* |
| H19B | 1.2415 | 0.3293 | 0.9770 | 0.046* |
| C20 | 1.02024(19) | 0.41084(12) | 0.89935(17) | 0.0518(5) |
| H20A | 0.9693 | 0.4583 | 0.8643 | 0.078* |
| H20B | 0.9659 | 0.3611 | 0.8917 | 0.078* |
| H20C | 1.0538 | 0.4227 | 0.9786 | 0.078* |
| C21 | 1.2197(2) | 0.47474(11) | 0.85252(19) | 0.0583(5) |
| H21A | 1.1678 | 0.5221 | 0.8184 | 0.088* |
| H21B | 1.2547 | 0.4864 | 0.9316 | 0.088* |
| H21C | 1.2904 | 0.4657 | 0.8147 | 0.088* |
| H1 | 0.492(2) | 0.1972(16) | 0.962(2) | 0.086(8)* |
| N1 | 1.18819(12) | 0.17428(8) | 0.94737(11) | 0.0366(3) |
| H1A | 1.2394 | 0.1866 | 1.0115 | 0.044* |
| O1 | 0.48243(11) | 0.17834(9) | 0.89232(12) | 0.0548(4) |
| O2 | 0.69880(10) | 0.23930(8) | 1.03121(9) | 0.0440(3) |
| O3 | 1.06367(19) | −0.07877(9) | 0.85780(15) | 0.0899(6) |
| O4 | 0.92575(14) | −0.02315(8) | 0.71204(14) | 0.0700(5) |
| O5 | 0.92788(11) | 0.27803(8) | 0.60840(9) | 0.0458(3) |
Source of material
The title compound was synthesized according to a reported procedure [5]. A mixture of 5,5-dimethyl-cyclohexane-1,3-dione (10 mmol), 3-methoxy-4-hydroxy-benzaldehyde (10 mmol), and 3-amino-2-butenoic acid methyl ester (10 mmol) in ethanol (100 mL) was refluxed for 2–3 h and then cooled to room temperature. After filtering the precipitates, they were sequentially washed with ice-cooled water and ethanol and then dried under a vacuum.
Experimental details
Hydrogen atoms were placed in calculated positions and were included in the refinement in the riding model approximation, with Uiso(H) set to 1.2Ueq(C, N) and 1.5Ueq for methyl groups.
Discussion
Several derivatives of 4-arylpolyhydroquinoline are endowed with different types of biological activities [1]. It has been reported that some 4-arylpolyhydroquinoline derivatives exhibit antimicrobial activity, growth stimulating effects, antifungal and plant growth regulation effects, antitumor activity, central nervous system (CNS) activity and hypotensive effect [2, 3] . Moreover, some 4-arylpolyhydroquinoline derivatives are well known for antihistaminic activity, platelet anti-aggregating activity and local anaesthetic activity, antiallergenic effect, antidepressant effect and as antiproliferation agents [4].
In the crystal structure of the title compound, the six-membered ring containing nitrogen atom shows a folding angle of 21.5° between the planes intersecting C9-C12-N1-C14-C15 and C12 -N1C14. The folding of the adjacent hexenone moiety shows a folding angle of 47° between the enone moiety (C17-C16-C15-C14-C19) and the aliphatic part (C19-C18-C17) of the ring (cf. see the figure). All geometric parameters are in the expected ranges.
References
1 Razavipour, S. T.; Behnammorshedi, M.; Razavipour, R.; Ajdary, M.: The toxic effect of nickel nanoparticles on oxidative stress and inflammatory markers. Biomed. Res. 26 (2015) 370–374.Search in Google Scholar
2 Wang, Y.; Ba, Y.: Studies on the chemical constituents of Radix astragali and their inhibitory effect on HepG2 proliferation. Biomed. Res. 26 (2015) 393–398.Search in Google Scholar
3 Wang, X.K.; Li, P.-W.; Yan, B.; Wang, B.-J.: 1,4-Dihydropyridine derivatives: synthesis and anti-hepatoma cancer activity. Lat. Am. J. Pharm. 35 (2016) 1692–1695.10.15199/62.2017.4.34Search in Google Scholar
4 Gündüz, M. G.; Celebi, S.; Kaygisiz, B.; Sim sek, R.; Erol, K.; Safak, C.: 7-Substituted hexahydroquinoline derivatives and their calcium channel modulator effects. Lat. Am. J. Pharm. 28 (2009) 922–926.Search in Google Scholar
5 Kahsai, A. W.; Cui, J.; Kaniskan, H.Ü.; Garner, P. P.; Fenteany, G.: Analogs of tetrahydroisoquinoline natural products that inhibit cell migration and target galectin-3 outside of its carbohydrate-binding site. J. Biol. Chem. 283 (2008) 24534–24545.10.1074/jbc.M800006200Search in Google Scholar PubMed PubMed Central
6 Bruker. APEX2, SAINT and SADABS. Brucker AXS Inc., Madison, Wisconsin, USA, (2009).Search in Google Scholar
7 Sheldrick, G. M.: A short history of SHELX. Acta Crystallogr. A64 (2008) 112–122.10.1107/S0108767307043930Search in Google Scholar PubMed
©2017 Wen-Jing Hao et al., published by De Gruyter, Berlin/Boston
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Articles in the same Issue
- Cover and Frontmatter
- Crystal structure of 2,5-diiodo-4-nitro-1H-imidazole hemihydrate, C6H4I4N6O5
- Crystal structure of catena-poly[μ2-2,2′-(1,3-phenylene)diacetato-κ4O,O′:O′′,O′′′)-(μ2-1,6-bis(2-methyl-1H-benzo[d]imidazol-1-yl)hexane-κ2N:N′)cadmium(II)], C32H34CdN4O4
- Crystal structure of poly[aqua-(2,2′-bipyridine-κN,N′)-(μ4-5,5′-(hexane-1,6-diyl)-bis(oxy)diisophthalato κ8O1,O2:O3,O4:O5,O6:O7,O8)manganese(II)], C21H21MnN2O7
- Crystal structure of poly-[(μ2-((1,3-bis(benzimidazol-1-yl)propane-κ2N:N′)(μ2-4-tert-butyl-phthalato-κ2O:O′)cobalt(II)] monohydrate, C29H30CoN4O5
- Crystal structure of 2-amino-4-(3,4,5-trimethoxy-phenyl)-5-(oxo-5,6,7,8-tetrahydro-4H-chromene)-3-carbonitrile – ethanol (1/1), C21H26N2O6
- Crystal structure of ethyl 1-benzyl-5-phenyl-1H-pyrazole-3-carboxylate, C19H18N2O2
- Crystal structure of 2-(1-benzyl-3-phenyl-1H-pyrazol-5-yl)-5-(4-nitrobenzylthio)-1,3,4-oxadiazole, C25H19N5O3S
- Structure and photochromism of 1,2-bis[2-methyl-5-(2-chlorophenyl)-3-thienyl]-3,3,4,4,5,5-hexafluorocyclopent-1-ene, C27H16Cl2F6S2
- The crystal structure of the Schiff base (E)-2,6-diisopropyl-N-(pyridin-4-ylmethylene)aniline, C18H22N2
- Crystal structure of (E)-2,4-dibromo-6-(((4-methyl-2-nitrophenyl)imino) methyl)phenol, C10H14Br2N2O3
- Crystal structure of (bis(2,2′-bipyridine-κ2N,N′))-(3,5-dinitrosalicylato-κ2O,O′)nickel(II), C27H18N6NiO7
- Crystal structure of 1-(diethoxy phosphonomethyl) 2-benzoyl-3-chloro-2-cyclohexen-1-ol, C18H24ClO5P
- Crystal structure of tetraaqua-bis(1,3-benzimidazol-3-ium-1,3-diacetato-κO)copper(II) hemihydrate, C22H27CuN4O12.50
- Crystal structure of 1α,11-dihydroxyeremophil-9-en-8-one, C15H24O3
- Crystal structure of 1-ferrocenylsulfonyl-1H-imidazo[4,5-b]pyridine, C16H13FeN3O2S
- Crystal structure of bis(μ2-azido-κ2N:N)-dichlorido-bis(μ2-2-(pyridin-2-yl)ethan-1-ol-κ2O,N)dicopper(II), C14H18Cl2Cu2N8O2
- Crystal structure of (5,15-cis-bis(2-hydroxy-1-naphthyl)-10-phenyl-20-(4-hydroxyphenyl)-porphyrinato)-(pyridine)-zinc(ii) pyridine solvate, C67H47N7O3Zn
- Crystal structure of (μ2-[2,2′-bis(diphenylphosphino)-1,1′-binaphthalene oxide-κ2O,P])-iodido copper(I), C44H32CuIOP2
- Crystal structure of 6,8-diphenyl-2-(4-fluorophenyl)-2,3-dihydroquinolin-4(3H)-one, C27H20FNO
- Crystal structure of 5,11,17,23-tetra(tert-butyl)-25,26,27,28-tetrahexoxycalix[4]arene, C68H104O4
- Crystal structure of N,N′–bis(pyridin-4-ylmethyl)pyrazine-2,3-dicarboxamide dihydrate, C18H20N6O4
- Crystal structure of a diaqua-bis(3,5-di(1H-imidazol-1-yl)pyridine-κN)-bis(2-(4-carboxy-phenyl)acetato-κO]manganese(II), C40H36MnN10O10
- Crystal structure of 4-(4-hydroxy-3-methoxy-phenyl)-2,7,7-trimethyl-5-oxo-1,4,5,6,7,8-hexahydro-quinoline-3-carboxylic acid methyl ester, C21H25NO5
- Crystal structure of (E)-4,4′-(ethene-1,2-diyl)bis(3-nitrobenzoic acid) 1.5 hydrate, C16H13N2O9.5
- Crystal structure of (E)-2-(5-(4-fluorophenyl)-3-(furan-2-yl)-4,5-dihydro-1H-pyrazol-1-yl)-5-((4-fluorophenyl)diazenyl)-4-methylthiazole, C23H17F2N5OS
- Crystal structure of the co-crystalline adduct 4-((4,4-dimethyl-2,6-dioxocyclohexylidene)methylamino)-N-(4,6-dimethylpyrimidin-2-yl)benzenesulfonamide - acetic acid (1/1), C21H24N4O4S ⋅ C2H4O2
- Synthesis and crystal structure of 2-((5-chlorobenzo[c][1,2,5]thiadiazol-4-yl)amino)-4,5-dihydro-1H-imidazol-3-ium tetraphenylborate, C33H29BClN5S
- Crystal structure of (4-chlorophenyl)(3-ferrocenyl-5-(trifluoromethyl)-1H-pyrazol-1-yl)methanone, C21H14ClF3FeN2O
- Crystal structure of (S)-benzyl 3-(benzylcarba-moyl)-3,4-dihydroisoquinoline-2(1H)-carboxylate, C25H24N2O3
- Crystal structure of 5-acetyl-3-(3-fluoro-4-morpholinophenyl)oxazolidin-2-one, C15H17FN2O4
- Crystal structure of 2-(4-fluorophenyl)-1,3-dimethyl-1H-perimidin-3-ium iodide, C19H16FIN2
- Crystal structure of methyl 1H-indole-2-carboxylate, C10H9NO2
- Crystal structure of 2,3-diphenyl-1-[(dipropylamino)acetyl]-1,3-diazaspiro[4.5]decan-4-one, C28H37N3O2
- Crystal structure of 1-(2H-1,3-benzodioxol-5-yl)-3-(1H-imidazol-1-yl)propan-1-one, C13H12N2O3
- Crystal structure of 2,9-dibromo-1,10-phenanthroline, C12H6Br2N2
- Crystal structure of 3-(adamantan-1-yl)-4-(4-fluorophenyl)-1H-1,2,4-triazole-5(4H)-thione, C18H20FN3S
- Crystal structure of trans-bis((E)-7-oxo-4-(phenyldiazenyl)cyclohepta-1,3,5-trien-1-olato)-κ2O,O′)-bis(pyridine-κN)cobalt(II), C36H28CoN6O4
- Crystal structure of 2-(4-methyl-3-phenylthiazol-2(3H)-ylidene)malononitrile, C13H9N3S
- Crystal structure of (Z)-3-(adamantan-1-yl)-1-(3-chlorophenyl)-S-benzylisothiourea, C24H27ClN2S
- Crystal structure of chlorido{[3-(η5-cyclopenta-dienyl)-2,2,3-trimethyl-1-phenylbutylidene] azanido-κN}[η2(N,O)-N,N-dimethylhydroxylaminato]titanium(IV), C20H27ClN2OTi
- Crystal Structure of 1,1′-dimethyl-[4,4′-bipyridine]-1,1′-diium tetrachloridozincate(II), C12H14Cl4N2Zn
- Crystal structure of 5-nitro-2-(pyrrolidin-1-yl)benzaldehyde, C11H12N2O3
- Crystal structure of 2,3-diphenyl-1-(morpholin-4-ylacetyl)-1,3-diazaspiro[4.5]decan-4-one, C26H31N3O3
- Crystal structure of 3,3-dimethyl-3,4-dihydro-1H-benzo[c]chromene-1,6(2H)-dione, C15H14O3
- Crystal structure of bis(2-(2-hydroxymethyl)pyridine-κ2N,O)-bis(pivalato-κO)nickel(II), C22H32N2NiO6
- Crystal structure of (1,10-phenanthroline-κ2N,N′)-bis(1H-pyrazole-3-carboxylato-κ2N,O)manganese(II) trihydrate, C20H20N6O7Mn
- The crystal structure of 3-aminopropan-1-aminium iodide, C3H11N2I
- Crystal structure of ethyl 1-(4-chlorophenyl)-5-methyl-1H-1,2,3-triazole-4 carboxylate, C12H12ClN3O2
- Crystal structure of 4,4′-((1Z,1′Z)-2,2′-(2,5-diethoxy-1,4-phenylene)bis(ethene-2,1-diyl))dipyridine, C24H24N2O2
- Crystal structure of (16S)-12,16-epoxy-11,14-dihydroxy-17(15/16)-abeo-3a,18-cyclo-8,11,13-abietatrien-7-one, C20H24O4
- Crystal structure of aquadichlorido(2,4,6-tri-2-pyridyl-1,3,5-triazine-κ3N,N′,N′′)nickel(II) monohydrate, C18H16Cl2N6NiO2
- Crystal structure of catena-poly[dichlorido-(μ-ethane-1,2-diyl-bis-(pyridyl-4-carboxylate-κN:N′)mercury(II)], C15H14Cl2HgN2O4
- Crystal structure of methyl 2-acetamido-5-chlorbenzoate, C10H10ClNO3
- Crystal structure of tetrakis(μ2-3,3-dimethylacrylato-κ2O,O′)-bis(2-aminopyrimidine-κN) dicopper(II), C28H38Cu2N6O8
- Crystal structure of 3-amino-8-methoxy-1-phenyl-1H-benzo[f]chromene-2-carbonitrile, C21H16N2O2
- Crystal structure of 4-(2-ammonioethyl)morpholin-4-ium dichloride monohydrate, C6H18Cl2N2O2
- Crystal structure of 1-(3-((5-bromo-2-hydroxybenzylidene)amino)phenyl)ethanone O-benzyl oxime, C22H19BrN2O2
- Crystal structure of 2-(4-(dimethylamino)-2-fluorophenyl)-1,3-bis(1H-1,2,4-triazol-1-yl)propan-2-ol monohydrate, C15H20FN7O2
- Crystal structure of 4-bromo-2-(1H-pyrazol-3-yl)phenol, C9H7BrN2O
- Crystal structure of 1,2,3,4,5-pentamethyl-1,3-cyclopentadiene, C10H16
Articles in the same Issue
- Cover and Frontmatter
- Crystal structure of 2,5-diiodo-4-nitro-1H-imidazole hemihydrate, C6H4I4N6O5
- Crystal structure of catena-poly[μ2-2,2′-(1,3-phenylene)diacetato-κ4O,O′:O′′,O′′′)-(μ2-1,6-bis(2-methyl-1H-benzo[d]imidazol-1-yl)hexane-κ2N:N′)cadmium(II)], C32H34CdN4O4
- Crystal structure of poly[aqua-(2,2′-bipyridine-κN,N′)-(μ4-5,5′-(hexane-1,6-diyl)-bis(oxy)diisophthalato κ8O1,O2:O3,O4:O5,O6:O7,O8)manganese(II)], C21H21MnN2O7
- Crystal structure of poly-[(μ2-((1,3-bis(benzimidazol-1-yl)propane-κ2N:N′)(μ2-4-tert-butyl-phthalato-κ2O:O′)cobalt(II)] monohydrate, C29H30CoN4O5
- Crystal structure of 2-amino-4-(3,4,5-trimethoxy-phenyl)-5-(oxo-5,6,7,8-tetrahydro-4H-chromene)-3-carbonitrile – ethanol (1/1), C21H26N2O6
- Crystal structure of ethyl 1-benzyl-5-phenyl-1H-pyrazole-3-carboxylate, C19H18N2O2
- Crystal structure of 2-(1-benzyl-3-phenyl-1H-pyrazol-5-yl)-5-(4-nitrobenzylthio)-1,3,4-oxadiazole, C25H19N5O3S
- Structure and photochromism of 1,2-bis[2-methyl-5-(2-chlorophenyl)-3-thienyl]-3,3,4,4,5,5-hexafluorocyclopent-1-ene, C27H16Cl2F6S2
- The crystal structure of the Schiff base (E)-2,6-diisopropyl-N-(pyridin-4-ylmethylene)aniline, C18H22N2
- Crystal structure of (E)-2,4-dibromo-6-(((4-methyl-2-nitrophenyl)imino) methyl)phenol, C10H14Br2N2O3
- Crystal structure of (bis(2,2′-bipyridine-κ2N,N′))-(3,5-dinitrosalicylato-κ2O,O′)nickel(II), C27H18N6NiO7
- Crystal structure of 1-(diethoxy phosphonomethyl) 2-benzoyl-3-chloro-2-cyclohexen-1-ol, C18H24ClO5P
- Crystal structure of tetraaqua-bis(1,3-benzimidazol-3-ium-1,3-diacetato-κO)copper(II) hemihydrate, C22H27CuN4O12.50
- Crystal structure of 1α,11-dihydroxyeremophil-9-en-8-one, C15H24O3
- Crystal structure of 1-ferrocenylsulfonyl-1H-imidazo[4,5-b]pyridine, C16H13FeN3O2S
- Crystal structure of bis(μ2-azido-κ2N:N)-dichlorido-bis(μ2-2-(pyridin-2-yl)ethan-1-ol-κ2O,N)dicopper(II), C14H18Cl2Cu2N8O2
- Crystal structure of (5,15-cis-bis(2-hydroxy-1-naphthyl)-10-phenyl-20-(4-hydroxyphenyl)-porphyrinato)-(pyridine)-zinc(ii) pyridine solvate, C67H47N7O3Zn
- Crystal structure of (μ2-[2,2′-bis(diphenylphosphino)-1,1′-binaphthalene oxide-κ2O,P])-iodido copper(I), C44H32CuIOP2
- Crystal structure of 6,8-diphenyl-2-(4-fluorophenyl)-2,3-dihydroquinolin-4(3H)-one, C27H20FNO
- Crystal structure of 5,11,17,23-tetra(tert-butyl)-25,26,27,28-tetrahexoxycalix[4]arene, C68H104O4
- Crystal structure of N,N′–bis(pyridin-4-ylmethyl)pyrazine-2,3-dicarboxamide dihydrate, C18H20N6O4
- Crystal structure of a diaqua-bis(3,5-di(1H-imidazol-1-yl)pyridine-κN)-bis(2-(4-carboxy-phenyl)acetato-κO]manganese(II), C40H36MnN10O10
- Crystal structure of 4-(4-hydroxy-3-methoxy-phenyl)-2,7,7-trimethyl-5-oxo-1,4,5,6,7,8-hexahydro-quinoline-3-carboxylic acid methyl ester, C21H25NO5
- Crystal structure of (E)-4,4′-(ethene-1,2-diyl)bis(3-nitrobenzoic acid) 1.5 hydrate, C16H13N2O9.5
- Crystal structure of (E)-2-(5-(4-fluorophenyl)-3-(furan-2-yl)-4,5-dihydro-1H-pyrazol-1-yl)-5-((4-fluorophenyl)diazenyl)-4-methylthiazole, C23H17F2N5OS
- Crystal structure of the co-crystalline adduct 4-((4,4-dimethyl-2,6-dioxocyclohexylidene)methylamino)-N-(4,6-dimethylpyrimidin-2-yl)benzenesulfonamide - acetic acid (1/1), C21H24N4O4S ⋅ C2H4O2
- Synthesis and crystal structure of 2-((5-chlorobenzo[c][1,2,5]thiadiazol-4-yl)amino)-4,5-dihydro-1H-imidazol-3-ium tetraphenylborate, C33H29BClN5S
- Crystal structure of (4-chlorophenyl)(3-ferrocenyl-5-(trifluoromethyl)-1H-pyrazol-1-yl)methanone, C21H14ClF3FeN2O
- Crystal structure of (S)-benzyl 3-(benzylcarba-moyl)-3,4-dihydroisoquinoline-2(1H)-carboxylate, C25H24N2O3
- Crystal structure of 5-acetyl-3-(3-fluoro-4-morpholinophenyl)oxazolidin-2-one, C15H17FN2O4
- Crystal structure of 2-(4-fluorophenyl)-1,3-dimethyl-1H-perimidin-3-ium iodide, C19H16FIN2
- Crystal structure of methyl 1H-indole-2-carboxylate, C10H9NO2
- Crystal structure of 2,3-diphenyl-1-[(dipropylamino)acetyl]-1,3-diazaspiro[4.5]decan-4-one, C28H37N3O2
- Crystal structure of 1-(2H-1,3-benzodioxol-5-yl)-3-(1H-imidazol-1-yl)propan-1-one, C13H12N2O3
- Crystal structure of 2,9-dibromo-1,10-phenanthroline, C12H6Br2N2
- Crystal structure of 3-(adamantan-1-yl)-4-(4-fluorophenyl)-1H-1,2,4-triazole-5(4H)-thione, C18H20FN3S
- Crystal structure of trans-bis((E)-7-oxo-4-(phenyldiazenyl)cyclohepta-1,3,5-trien-1-olato)-κ2O,O′)-bis(pyridine-κN)cobalt(II), C36H28CoN6O4
- Crystal structure of 2-(4-methyl-3-phenylthiazol-2(3H)-ylidene)malononitrile, C13H9N3S
- Crystal structure of (Z)-3-(adamantan-1-yl)-1-(3-chlorophenyl)-S-benzylisothiourea, C24H27ClN2S
- Crystal structure of chlorido{[3-(η5-cyclopenta-dienyl)-2,2,3-trimethyl-1-phenylbutylidene] azanido-κN}[η2(N,O)-N,N-dimethylhydroxylaminato]titanium(IV), C20H27ClN2OTi
- Crystal Structure of 1,1′-dimethyl-[4,4′-bipyridine]-1,1′-diium tetrachloridozincate(II), C12H14Cl4N2Zn
- Crystal structure of 5-nitro-2-(pyrrolidin-1-yl)benzaldehyde, C11H12N2O3
- Crystal structure of 2,3-diphenyl-1-(morpholin-4-ylacetyl)-1,3-diazaspiro[4.5]decan-4-one, C26H31N3O3
- Crystal structure of 3,3-dimethyl-3,4-dihydro-1H-benzo[c]chromene-1,6(2H)-dione, C15H14O3
- Crystal structure of bis(2-(2-hydroxymethyl)pyridine-κ2N,O)-bis(pivalato-κO)nickel(II), C22H32N2NiO6
- Crystal structure of (1,10-phenanthroline-κ2N,N′)-bis(1H-pyrazole-3-carboxylato-κ2N,O)manganese(II) trihydrate, C20H20N6O7Mn
- The crystal structure of 3-aminopropan-1-aminium iodide, C3H11N2I
- Crystal structure of ethyl 1-(4-chlorophenyl)-5-methyl-1H-1,2,3-triazole-4 carboxylate, C12H12ClN3O2
- Crystal structure of 4,4′-((1Z,1′Z)-2,2′-(2,5-diethoxy-1,4-phenylene)bis(ethene-2,1-diyl))dipyridine, C24H24N2O2
- Crystal structure of (16S)-12,16-epoxy-11,14-dihydroxy-17(15/16)-abeo-3a,18-cyclo-8,11,13-abietatrien-7-one, C20H24O4
- Crystal structure of aquadichlorido(2,4,6-tri-2-pyridyl-1,3,5-triazine-κ3N,N′,N′′)nickel(II) monohydrate, C18H16Cl2N6NiO2
- Crystal structure of catena-poly[dichlorido-(μ-ethane-1,2-diyl-bis-(pyridyl-4-carboxylate-κN:N′)mercury(II)], C15H14Cl2HgN2O4
- Crystal structure of methyl 2-acetamido-5-chlorbenzoate, C10H10ClNO3
- Crystal structure of tetrakis(μ2-3,3-dimethylacrylato-κ2O,O′)-bis(2-aminopyrimidine-κN) dicopper(II), C28H38Cu2N6O8
- Crystal structure of 3-amino-8-methoxy-1-phenyl-1H-benzo[f]chromene-2-carbonitrile, C21H16N2O2
- Crystal structure of 4-(2-ammonioethyl)morpholin-4-ium dichloride monohydrate, C6H18Cl2N2O2
- Crystal structure of 1-(3-((5-bromo-2-hydroxybenzylidene)amino)phenyl)ethanone O-benzyl oxime, C22H19BrN2O2
- Crystal structure of 2-(4-(dimethylamino)-2-fluorophenyl)-1,3-bis(1H-1,2,4-triazol-1-yl)propan-2-ol monohydrate, C15H20FN7O2
- Crystal structure of 4-bromo-2-(1H-pyrazol-3-yl)phenol, C9H7BrN2O
- Crystal structure of 1,2,3,4,5-pentamethyl-1,3-cyclopentadiene, C10H16